The Newborn Screening Market, projecting a Compound Annual Growth Rate (CAGR) of 7.9% from 2023 to 2030. The market is expected to reach $2.49 billion by 2030, driven by factors such as the increasing prevalence of congenital heart diseases and genetic disorders, a rising neonatal population, and growing awareness regarding the importance of newborn screening.
Market Dynamics and Challenges
While the Newborn Screening Market is poised for significant expansion, certain challenges could hinder its growth. The shortage of healthcare professionals and the advent of non-invasive prenatal screening technologies are identified as potential constraints. However, the market is expected to benefit from government programs, legislation promoting newborn screening, and opportunities arising in emerging economies.
Top 10 Companies Shaping the Newborn Screening Market: https://meticulousblog.org/top-10-companies-in-newborn-screening-market/
Meticulous Research® highlights the top 10 companies playing pivotal roles in shaping the Newborn Screening Market:
1. Thermo Fisher Scientific Inc. (U.S.) - A global company offering products and services across various sectors, operating in the newborn screening market through the Life Sciences Solutions segment.
2. ARCHIMED Group (France) - A global investment firm specializing in healthcare industry transactions, focusing on small-cap and mid-cap buyout transactions.
3. PerkinElmer, Inc. (U.S.) - A multinational company providing products, solutions, and services for the life sciences, diagnostics, and applied markets, operating in the newborn screening market through the Diagnostics business segment.
4. Medtronic plc (Ireland) - A healthcare technology company operating in the newborn screening market through the Medical Surgical Portfolio segment, offering biomedical engineering products.
5. Trivitron Healthcare Pvt Ltd. (India) - A medical technology company with a global presence in over 180 countries, manufacturing and distributing medical technology products.
6. Bio-Rad Laboratories, Inc. (U.S.) - A distributor and manufacturer of clinical diagnostics products and life science research, operating in the newborn screening market through the Clinical Diagnostics segment.
7. Demant A/S (Denmark) - A hearing healthcare and audio technology group providing hearing care and diagnoses for hearing disorders, operating in the newborn screening market through the Hearing Healthcare segment.
8. Baebies, Inc. (U.S.) - A medical technology company utilizing digital microfluidics to commercialize products for early disease detection and comprehensive diagnostic solutions.
9. ZenTech s.a. (Belgium) - A biotechnology company specializing in In Vitro Diagnostics (IVD) and Radio Isotopic Assays (RIA) for prenatal, neonatal, and pediatric use.
10. Hoffmann-La Roche Ltd (Switzerland) - A pharmaceutical and diagnostics company operating in the newborn screening market through the Diagnostics segment, offering differentiated medicines and in vitro diagnostics.

Download Free Sample Report Here: https://www.meticulousresearch.com/download-sample-report/cp_id=5367
Meticulous Research® Insights
Meticulous Research®'s latest publication predicts a noteworthy growth of 7.9% in the Newborn Screening Market during the forecast period of 2023-2030. The comprehensive report provides detailed insights into the financial performance, key products, company strategies, partnerships, and acquisitions of these industry leaders.
About Meticulous Research®
Meticulous Research® is a leading provider of market intelligence and advisory services, committed to delivering high-quality insights and strategic business solutions globally. With a meticulous approach to research and analysis, the firm aims to provide valuable information for decision-making and business growth.
Contact Us:
Meticulous Research®
Email- [email protected]
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research